FDA Adverse Event Death Summary report: N

DEEP BRAIN STIMULATION LEAD

MDR report key: 986257 · Received January 28, 2008

Report

Report Number
2182207-2008-00426
Event Type
Death
Date Received
January 28, 2008
Report Date
January 4, 2008
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
MHY
PMA / PMN Number
P960009
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

.

Description of Event or Problem · 1

JOURNAL REFERENCE: SCHUPBACH M. WELTER ML, BONNET AM, ET AL. MORTALITY IN PATIENTS WITH PARKINSONS DISEASE TREATED BY STIMULATION OF THE SUBTHALAMIC NUCLEUS. MOV DISORD. 2006; 22(2):257-261. THE ARTICLE DESCRIBES THE RESULTS OF A STUDY INVOLVING 171 PATIENTS BEING TREATED WITH BILATERAL DEEP BRAIN STIMULATION (DBS) FOR SYMPTOMS RELATED TO ADVANCED PARKINSONS DISEASE. THE GOAL OF THE STUDY WAS TO ASSESS MORTALITY AND CAUSES OF DEATH. STUDY PATIENTS WERE EVALUATED UNTIL DEATH OR JULY 2005. FOREIGN MORTALITY RATES AND UNITED STATES HISTORICAL COMPARISONS WERE USED. SIXTEEN PATIENTS DIED DURING THE STUDY PERIOD. EIGHT DEATHS WERE CLASSIFIED AS UNRELATED TO DBS TREATMENT. TWO WERE THOUGHT TO HAVE SOME RELATIONSHIP TO DBS TREATMENT AND THE SIX REMAINING COULD NOT RULE OUT THE POSSIBILITY OF SOME RELATIONSHIP TO DBS THERAPY. A FEMALE PT EXPERIENCED MAJOR DEPRESSION AND COMMITTED SUICIDE BY HANGING. IT WAS HYPOTHESIZED THAT THE POSTOPERATIVE DEPRESSION WAS CAUSED BY COMPLETE WITHDRAWAL OF L-DOPA. IN ADDITION, IT CANNOT BE EXCLUDED, THAT STN STIMULATION WAS DIRECTLY INVOLVED IN THE DECOMPENSATION OF PRE-EXISTING PSYCHIATRIC DISORDERED. THE PT EXPERIENCED MAJOR DEPRESSION AS A YOUTH AND SUFFERED ONE RELAPSE BEFORE SURGERY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 DEEP BRAIN STIMULATION LEAD MHY MEDTRONIC NEUROMODULATION UNK UNK

Patients

Seq Age Sex Outcome Treatment
1 57 YR Death LEAD EXTENSION (N=2)| IPG DUAL OUTPUT (1)| DBS LEAD UNK (N=1)| IPG SINGLE OUTPUT (N=2)